ROYAL BANK OF CANADA - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 40 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q3 2021$6,0000.0%6,0000.0%0.00%
Q2 2021$6,0000.0%6,0000.0%0.00%
Q1 2021$6,000
-14.3%
6,0000.0%0.00%
Q4 2020$7,000
+16.7%
6,0000.0%0.00%
Q3 2020$6,000
-14.3%
6,0000.0%0.00%
Q2 2020$7,000
+16.7%
6,0000.0%0.00%
Q1 2020$6,000
-99.7%
6,000
-99.7%
0.00%
-100.0%
Q4 2019$2,289,000
+38050.0%
2,001,000
+33250.0%
0.00%
Q1 2018$6,0000.0%6,0000.0%0.00%
Q4 2017$6,000
-25.0%
6,000
-25.0%
0.00%
Q3 2017$8,000
+33.3%
8,000
+33.3%
0.00%
Q2 2017$6,000
+200.0%
6,000
+200.0%
0.00%
Q1 2017$2,0000.0%2,0000.0%0.00%
Q4 2016$2,0000.0%2,0000.0%0.00%
Q3 2016$2,000
+100.0%
2,0000.0%0.00%
Q2 2016$1,0002,0000.00%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q1 2021
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 9,821,000$11,314,0001.07%
TFG Asset Management GP Ltd 6,000,000$6,883,0001.02%
Alken Asset Management Ltd 400,000$461,0000.79%
Lombard Odier Asset Management (Europe) Ltd 6,525,000$7,470,0000.54%
CSS LLC/IL 8,000,000$9,158,0000.51%
IRON Financial LLC 505,000$578,0000.28%
MACKAY SHIELDS LLC 32,796,000$37,597,0000.26%
OSTRUM ASSET MANAGEMENT 400$459,0000.22%
RWC Asset Management LLP 4,400,000$5,037,0000.20%
PALISADE CAPITAL MANAGEMENT, LP 4,871,000$5,580,0000.16%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders